Egenesis Stock

egenesisbio.comBioTechFounded: 2015

eGenesis’s goal is to transform the field of transplantation by offering safe and effective organs, tissues, and cells to patients in need by harnessing cutting-edge gene editing technologies to address the key issues that have impeded xenotransplantation to date.

Register for Details

For more details on financing and valuation for Egenesis, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Other companies like Egenesis in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$197.73MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM